Treatment for erectile dysfunction among older men in Northern Ireland.


Journal

International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 17 05 2018
accepted: 14 08 2018
pubmed: 18 9 2018
medline: 29 1 2019
entrez: 18 9 2018
Statut: ppublish

Résumé

Erectile dysfunction is common among older men; however, diagnosis and treatment compared to reported prevalence is low. We aim to identify the degree to which older men are offered treatment for the condition and determine the level of unmet need within Northern Ireland (NI). Analysis of data collected using a cross-sectional survey was conducted for men aged ≥60 years with data weighted to the NI population by age and deprivation. Respondents answered questions on sociodemographic factors, health-related characteristics, ability to function sexually, level of sexual interest and activity, and any treatment offered to improve erections in the last 3 years. Results are presented as proportions reporting treatment receipt, with differences by respondent characteristics assessed using chi-square tests and multivariable logistic regression. Among 2597 respondents, 46.5% reported erectile dysfunction. One quarter (25.8%) recalled being offered either medication, devices, or specialised services to improve erections. The offer of treatment was associated with younger age, being separated or divorced, higher number of long-term conditions, and greater interest in sex. Of men reporting erectile dysfunction and offered medication, 28.8% found them helpful and currently use them. As a result of not being offered treatment or not finding treatment useful, 93% of men reporting erectile dysfunction have no help with the condition. This is a likely consequence of treatment availability through the NHS in NI, but also suggests that healthcare professionals need to engage more proactively with older men, discussing sexual health routinely and following up those treated for the condition.

Sections du résumé

BACKGROUND BACKGROUND
Erectile dysfunction is common among older men; however, diagnosis and treatment compared to reported prevalence is low. We aim to identify the degree to which older men are offered treatment for the condition and determine the level of unmet need within Northern Ireland (NI).
METHODOLOGY METHODS
Analysis of data collected using a cross-sectional survey was conducted for men aged ≥60 years with data weighted to the NI population by age and deprivation. Respondents answered questions on sociodemographic factors, health-related characteristics, ability to function sexually, level of sexual interest and activity, and any treatment offered to improve erections in the last 3 years. Results are presented as proportions reporting treatment receipt, with differences by respondent characteristics assessed using chi-square tests and multivariable logistic regression.
RESULTS RESULTS
Among 2597 respondents, 46.5% reported erectile dysfunction. One quarter (25.8%) recalled being offered either medication, devices, or specialised services to improve erections. The offer of treatment was associated with younger age, being separated or divorced, higher number of long-term conditions, and greater interest in sex. Of men reporting erectile dysfunction and offered medication, 28.8% found them helpful and currently use them.
CONCLUSIONS CONCLUSIONS
As a result of not being offered treatment or not finding treatment useful, 93% of men reporting erectile dysfunction have no help with the condition. This is a likely consequence of treatment availability through the NHS in NI, but also suggests that healthcare professionals need to engage more proactively with older men, discussing sexual health routinely and following up those treated for the condition.

Identifiants

pubmed: 30222241
doi: 10.1111/ijcp.13259
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13259

Subventions

Organisme : Movember Foundation
ID : BO26/MO
Organisme : Prostate Cancer UK
ID : BO26/MO
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

David W Donnelly (DW)

Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, UK.

Therese Kearney (T)

Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, UK.

Eilis McCaughan (E)

Institute of Nursing and Health Research, Ulster University, Coleraine, UK.

Amy Downing (A)

Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.

David Weller (D)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Adam W Glaser (AW)

Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.

Anna Gavin (A)

Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH